Radius Health Initiates Phase 3 wearABLe Study of Abaloparatide-Patch in Postmenopausal Osteoporosis Patients at High Risk for Fracture
Radius Recycling, Inc. - Class A (RDUS)
Last radius recycling, inc. - class a earnings: 2/27 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.radiuspharm.com
Company Research
Source: GlobeNewswire
Abaloparatide-Patch patient assessment study results demonstrated high patient acceptability and self-administration accuracy over a 29-day periodLevels of PINP, a biomarker for bone formation, after one month in patient assessment study were consistent with results in Phase 3 ACTIVE study of TYMLOS® (abaloparatide) injectionAbaloparatide-Patch SPA agreement with FDA includes a non-inferiority margin of 2% for the difference in percentage change in lumbar spine BMD at 12 months (i.e. preserves ~77% of the historical effect of TYMLOS) WALTHAM, Mass., Aug. 05, 2019 (GLOBE NEWSWIRE) -- Radius Health, Inc. (“Radius” or the “Company”) (Nasdaq: RDUS) today announced the randomization of the first patient in the Phase 3 wearABLe clinical trial studying the safety and efficacy of abaloparatide-transdermal patch (abaloparatide-patch) in the treatment of postmenopausal patients with osteoporosis at high risk for fracture. Prior to initiating the study, the Company achieved a Special Protoc
Show less
Read more
Impact Snapshot
Event Time:
RDUS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RDUS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RDUS alerts
High impacting Radius Recycling, Inc. - Class A news events
Weekly update
A roundup of the hottest topics
RDUS
News
- Radius Recycling Publishes Fiscal Year 2024 Sustainability ReportGlobeNewswire
- Radius Pharmaceuticals Expands Abaloparatide Licensing Agreement with Theramex Granting Additional Commercialization Rights Including Mexico, Canada, South Africa, Israel, and RussiaAccesswire
- Radius Recycling, Inc. (NASDAQ: RDUS) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.MarketBeat
- Radius Recycling, Inc. (NASDAQ: RDUS) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $22.00 price target on the stock.MarketBeat
- Radius Recycling, Inc. (NASDAQ: RDUS) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.MarketBeat